Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum polystyrene sulfonate powder in hemodialysis patients with hyperphosphatemia
ChiCTR2000032392Phase 2Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lanthanum polystyrene sulfonate in hyperphosphatemia (4 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Phosphate concentrations and Plasma lanthanum concentrations. Started Apr 2020; status: recruiting.
02
Drugs
lanthanum polystyrene sulfonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on ChiCTR2000032392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032392.